1Ghazeeri G, Kutteh WH, Bryer-Ash M, et al. Effect of rosiglitazone on Spontaneous and clomiphene citrate-induced ovulation in women with Polycystic ovary syndrome. Fertil Steril,2003,79 : 562 -566. 被引量：1
2Seli E, Duleba AJ. Optimizingovulation induction inwomen with polycystic ovary syndrome. Curr Opin Obstet Gyneco1,2002,14:245. 被引量：1
3Valle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetesmellitus. Fertil Steril,2002,77 : 1095. 被引量：1
4Ghazeeri G, Kutteh WH, Bryer Ash M, et al. Effectof ros glitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. Fertil Steril,2003 ,79 :562. 被引量：1
5Teede HI, Meyer C, Norman RJ. Insulin sensitisers in the treatment of polycystic ovary syndrome. Expert Opin Pharmacothcr, 2005,6 : 2419- 2427. 被引量：1
3The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Grou. Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome[J].Fertility and Sterility,2004.19. 被引量：1
4Ghazeeri G,Kuteh W H,Bryer-Ash M. Effect of rosiglitazone on Spontaneous and clomiphene citrate-induced ovulation in women with Polycystic ovary syndrome[J].Fertility and Sterility,2003.562.doi:10.1016/S0015-0282(02)04843-4. 被引量：1
5Troll B,Flyvbjerg A,kesmodel U. Efficacy of metform inobese and non-obese women with polycystic ovary syndrome:Arandomized,double-blinded,plaeebo-controlled cross-over trial[J].Human Reproduction,2007,(11):2967.doi:10.1093/humrep/dem271. 被引量：1
